Sunscreen: check. Water bottle: check. Beach ball: check. Insulin cooler….? Yep. For those of us who use insulin, summer heat creates an extra level of complexity and worry.
The real question we all ask ourselves in the heat of the summer is whether our fun-in-the-sun will cook our insulin and leave us having-not-so-much-fun in an air conditioned ICU unit?
There’s a whole industry of solutions dedicated to helping us keep our insulin cool, ranging from…
Read more »
It’s not too often we have a new insulin making its way on the scene, so we were excited to hear that Novo Nordisk filed two applications with the FDA for a new “ultra long acting” insulin called Degludec, and another for something called DegludecPlus, a combination of degludec and insulin aspart (Novolog), which would be available in an insulin pen in a fixed 70% degludec/30% Novolog ratio. The company is hoping for FDA approval…
Read more »
It’s no surprise to our readers that one of the biggest issues with current diabetes management is the lag time of our current fast-acting insulins.
Although light years ahead of what patients had in the past, current fast-acting insulins still aren’t quite up to snuff to handle post-prandial spikes. This is becomes a barrier for developing an Artificial Pancreas, as the insulin can’t respond quickly enough to sensor data in a closed-loop system.
The topic…
Read more »
By
AmyT on
September 16, 2010
Calibra Medical’s new insulin “patch pen,” brand-named Finesse, has been approved by the FDA and performed extremely well in recent patient studies. The product could be a huge hit — if the company can secure the financial backing it needs to get production off the ground, according to the physician leading their research charge.
So let’s start at the beginning here: What the heck is a “patch pen,” anyway? That’s what I wanted to know.…
Read more »
